Table 1 Baseline demographics of the trial population
Demographic feature | All | Intranasal dexmedetomidine | Intranasal esketamine |
|---|---|---|---|
Number of patients | 30 | 15 | 15 |
Age (mo) mean | 24 | 26 | 23 |
Weight (kg) mean | 12,7 | 12,9 | 12,4 |
Male (%) | 19 (63,3) | 8 (53,3) | 11 (73,3) |
Female (%) | 11 (36,7) | 7 (46,7) | 4 (26,7) |
Laceration | 27 | 12 | 15 |
Burn | 3 | 3 | 0 |
Missing | 0 | 0 | 0 |